• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在缺乏白细胞介素2信号传导的情况下,激动剂诱导的CD25 + Foxp3 +调节性T细胞的发育与功能

Development and function of agonist-induced CD25+Foxp3+ regulatory T cells in the absence of interleukin 2 signaling.

作者信息

D'Cruz Louise M, Klein Ludger

机构信息

Research Institute of Molecular Pathology, 1030 Vienna, Austria.

出版信息

Nat Immunol. 2005 Nov;6(11):1152-9. doi: 10.1038/ni1264. Epub 2005 Oct 16.

DOI:10.1038/ni1264
PMID:16227983
Abstract

Interleukin 2 signaling is believed to be critically involved in several aspects of CD25(+) CD4(+) regulatory T cell biology, such as intrathymic development, peripheral survival and suppressive function. Here we have analyzed the effects of interleukin 2 or CD25 deficiency on agonist-driven thymic development and the peripheral homeostasis of an antigen-specific population of regulatory T cells positive for forkhead family transcription factor Foxp3 and have correlated our observations with polyclonal suppressor populations. We found that the differentiation, acquisition of functional capacity and formation of a sizeable pool of suppressor T cells in the thymus was independent of interleukin 2 signaling, but that interleukin 2 was essential for the survival of mature Foxp3(+) regulatory T cells.

摘要

白细胞介素2信号传导被认为在CD25(+) CD4(+)调节性T细胞生物学的几个方面起着关键作用,如胸腺内发育、外周存活和抑制功能。在此,我们分析了白细胞介素2或CD25缺乏对激动剂驱动的胸腺发育以及叉头家族转录因子Foxp3阳性的抗原特异性调节性T细胞群体的外周稳态的影响,并将我们的观察结果与多克隆抑制细胞群体进行了关联。我们发现,胸腺中抑制性T细胞的分化、功能能力的获得以及相当数量细胞库的形成与白细胞介素2信号传导无关,但白细胞介素2对于成熟Foxp3(+)调节性T细胞的存活至关重要。

相似文献

1
Development and function of agonist-induced CD25+Foxp3+ regulatory T cells in the absence of interleukin 2 signaling.在缺乏白细胞介素2信号传导的情况下,激动剂诱导的CD25 + Foxp3 +调节性T细胞的发育与功能
Nat Immunol. 2005 Nov;6(11):1152-9. doi: 10.1038/ni1264. Epub 2005 Oct 16.
2
A function for interleukin 2 in Foxp3-expressing regulatory T cells.白细胞介素2在表达Foxp3的调节性T细胞中的作用。
Nat Immunol. 2005 Nov;6(11):1142-51. doi: 10.1038/ni1263. Epub 2005 Oct 16.
3
TGFbeta regulates the CD4+CD25+ T-cell pool and the expression of Foxp3 in vivo.转化生长因子β在体内调节CD4+CD25+ T细胞库及叉头框蛋白3的表达。
Int Immunol. 2004 Sep;16(9):1241-9. doi: 10.1093/intimm/dxh126. Epub 2004 Jul 12.
4
Foxp3 programs the development and function of CD4+CD25+ regulatory T cells.Foxp3对CD4+CD25+调节性T细胞的发育和功能进行编程。
Nat Immunol. 2003 Apr;4(4):330-6. doi: 10.1038/ni904. Epub 2003 Mar 3.
5
Rapamycin, not cyclosporine, permits thymic generation and peripheral preservation of CD4+ CD25+ FoxP3+ T cells.雷帕霉素而非环孢素能使CD4+ CD25+ FoxP3+ T细胞在胸腺中生成并在外周得以保存。
Bone Marrow Transplant. 2007 May;39(9):537-45. doi: 10.1038/sj.bmt.1705628. Epub 2007 Mar 12.
6
IL-2Rbeta links IL-2R signaling with Foxp3 expression.白细胞介素-2受体β链将白细胞介素-2受体信号传导与叉头框蛋白3表达联系起来。
Eur J Immunol. 2007 Jul;37(7):1817-26. doi: 10.1002/eji.200737101.
7
Impaired T cell receptor signaling in Foxp3+ CD4 T cells.Foxp3+ CD4 T细胞中T细胞受体信号传导受损。
Ann N Y Acad Sci. 2007 Apr;1103:167-78. doi: 10.1196/annals.1394.022. Epub 2007 Mar 21.
8
Development of mouse CD4(+)CD25(+)Foxp3(+) regulatory T cells in xenogeneic pig thymic grafts.异种猪胸腺移植物中小鼠CD4(+)CD25(+)Foxp3(+)调节性T细胞的发育
Transpl Immunol. 2009 Jan;20(3):180-5. doi: 10.1016/j.trim.2008.09.006. Epub 2008 Oct 7.
9
Protein kinase B/Akt signals impair Th17 differentiation and support natural regulatory T cell function and induced regulatory T cell formation.蛋白激酶B/Akt信号会损害辅助性T细胞17(Th17)的分化,并支持自然调节性T细胞功能以及诱导调节性T细胞的形成。
J Immunol. 2009 Nov 15;183(10):6124-34. doi: 10.4049/jimmunol.0900246. Epub 2009 Oct 19.
10
Recent thymic origin, differentiation, and turnover of regulatory T cells.调节性T细胞的近期胸腺起源、分化及更新
J Leukoc Biol. 2008 Nov;84(5):1287-97. doi: 10.1189/jlb.0308201. Epub 2008 Aug 5.

引用本文的文献

1
Regulatory T cells epigenetically reprogrammed from autoreactive effector T cells mitigate established autoimmunity.从自身反应性效应T细胞经表观遗传重编程而来的调节性T细胞可减轻已确立的自身免疫。
bioRxiv. 2025 Jul 28:2025.07.24.665398. doi: 10.1101/2025.07.24.665398.
2
Therapeutic potential of NRF2 activating drug RTA-408 in suppressing T cell effector responses and inflammatory bowel disease.NRF2激活药物RTA-408在抑制T细胞效应反应和炎症性肠病方面的治疗潜力。
J Immunol. 2025 Aug 1;214(8):1951-1968. doi: 10.1093/jimmun/vkaf117.
3
Aged regulatory T cells fail to control autoimmune lacrimal gland pathogenic CD4 T cells.
衰老的调节性T细胞无法控制自身免疫性泪腺致病性CD4 T细胞。
Geroscience. 2025 Mar 7. doi: 10.1007/s11357-025-01576-y.
4
Current landscape and future prospects of interleukin-2 receptor (IL-2R) agonists in cancer immunotherapy.白细胞介素-2受体(IL-2R)激动剂在癌症免疫治疗中的现状与未来前景
Oncoimmunology. 2025 Dec;14(1):2452654. doi: 10.1080/2162402X.2025.2452654. Epub 2025 Jan 15.
5
Effects of two immunosuppression regimens on T-lymphocyte subsets in elderly kidney transplant recipients.两种免疫抑制方案对老年肾移植受者 T 淋巴细胞亚群的影响。
Front Immunol. 2024 Sep 20;15:1405855. doi: 10.3389/fimmu.2024.1405855. eCollection 2024.
6
Phase I Study of Simlukafusp Alfa (FAP-IL2v) with or without Atezolizumab in Japanese Patients with Advanced Solid Tumors.Simulkafusp Alfa(FAP-IL2v)联合或不联合阿替利珠单抗治疗日本晚期实体瘤患者的 I 期研究。
Cancer Res Commun. 2024 Sep 1;4(9):2349-2358. doi: 10.1158/2767-9764.CRC-24-0185.
7
Interleukin-2 signaling in the regulation of T cell biology in autoimmunity and cancer.白细胞介素-2 信号在自身免疫和癌症中 T 细胞生物学的调节作用。
Immunity. 2024 Mar 12;57(3):414-428. doi: 10.1016/j.immuni.2024.02.001.
8
"IL-2 immunotherapy for targeting regulatory T cells in autoimmunity".“针对自身免疫中的调节性 T 细胞的 IL-2 免疫疗法”。
Genes Immun. 2023 Oct;24(5):248-262. doi: 10.1038/s41435-023-00221-y. Epub 2023 Sep 23.
9
The potential of regulatory T cell-based therapies for alopecia areata.基于调节性 T 细胞的疗法治疗斑秃的潜力。
Front Immunol. 2023 May 2;14:1111547. doi: 10.3389/fimmu.2023.1111547. eCollection 2023.
10
STAT5b: A master regulator of key biological pathways.STAT5b:关键生物途径的主调控因子。
Front Immunol. 2023 Jan 23;13:1025373. doi: 10.3389/fimmu.2022.1025373. eCollection 2022.